世界の生物製剤市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV03235)
◆英語タイトル:Global Biological Drugs Market Insights and Forecast to 2026
◆商品コード:QYR20NV03235
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは生物製剤の世界市場について調査・分析した資料です。種類別(治療用タンパク質、モノクローナル抗体、ワクチン)の市場規模、用途別(病院、外来外科センター、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別生物製剤の競争状況、市場シェア
・世界の生物製剤市場:種類別市場規模 2015年-2020年(治療用タンパク質、モノクローナル抗体、ワクチン)
・世界の生物製剤市場:種類別市場規模予測 2021年-2026年(治療用タンパク質、モノクローナル抗体、ワクチン)
・世界の生物製剤市場:用途別市場規模 2015年-2020年(病院、外来外科センター、その他)
・世界の生物製剤市場:用途別市場規模予測 2021年-2026年(病院、外来外科センター、その他)
・北米の生物製剤市場分析:米国、カナダ
・ヨーロッパの生物製剤市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの生物製剤市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の生物製剤市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの生物製剤市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Bristol-Myers Squibb、Eli Lilly、Takeda、Pfizer、Amgen、F. Hoffmann-La Roche、Johnson & Johnson、Merck、Abbott Laboratories、Baxter、Novartis、Biogen、GlaxoSmithKline
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The world biological drugs market is predicted to gain momentum with rising prevalence of chronic diseases such as cancer and diabetes across the globe. Demand for biological drugs could swell with the expansion of geriatric population at the global level. Currently growing inclination toward adoption of personalized medicines and strong research and development efforts taken to introduce new and powerful biological drugs are foretold to set the tone for a significant rise in demand.

Market Analysis and Insights: Global Biological Drugs Market
The global Biological Drugs market size is projected to reach US$ 292500 million by 2026, from US$ 268200 million in 2020, at a CAGR of 8.2%% during 2021-2026.

Global Biological Drugs Scope and Market Size
Biological Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Biological Drugs market is segmented into
Therapeutic Protein
Monoclonal Antibody
Vaccine

Segment by Application, the Biological Drugs market is segmented into
Hospitals
Ambulatory Surgical Centers
Others

Regional and Country-level Analysis
The Biological Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biological Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biological Drugs Market Share Analysis
Biological Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biological Drugs business, the date to enter into the Biological Drugs market, Biological Drugs product introduction, recent developments, etc.

The major vendors covered:
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline

【レポートの目次】

1 Study Coverage
1.1 Biological Drugs Product Introduction
1.2 Market Segments
1.3 Key Biological Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biological Drugs Market Size Growth Rate by Type
1.4.2 Therapeutic Protein
1.4.3 Monoclonal Antibody
1.4.4 Vaccine
1.5 Market by Application
1.5.1 Global Biological Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Biological Drugs Market Size, Estimates and Forecasts
2.1.1 Global Biological Drugs Revenue 2015-2026
2.1.2 Global Biological Drugs Sales 2015-2026
2.2 Global Biological Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biological Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biological Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Biological Drugs Competitor Landscape by Players
3.1 Biological Drugs Sales by Manufacturers
3.1.1 Biological Drugs Sales by Manufacturers (2015-2020)
3.1.2 Biological Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Biological Drugs Revenue by Manufacturers
3.2.1 Biological Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Biological Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biological Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biological Drugs Revenue in 2019
3.2.5 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biological Drugs Price by Manufacturers
3.4 Biological Drugs Manufacturing Base Distribution, Product Types
3.4.1 Biological Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biological Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Biological Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Biological Drugs Market Size by Type (2015-2020)
4.1.1 Global Biological Drugs Sales by Type (2015-2020)
4.1.2 Global Biological Drugs Revenue by Type (2015-2020)
4.1.3 Biological Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biological Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Biological Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Biological Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Biological Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biological Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Biological Drugs Market Size by Application (2015-2020)
5.1.1 Global Biological Drugs Sales by Application (2015-2020)
5.1.2 Global Biological Drugs Revenue by Application (2015-2020)
5.1.3 Biological Drugs Price by Application (2015-2020)
5.2 Biological Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Biological Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Biological Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Biological Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Biological Drugs by Country
6.1.1 North America Biological Drugs Sales by Country
6.1.2 North America Biological Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biological Drugs Market Facts & Figures by Type
6.3 North America Biological Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Biological Drugs by Country
7.1.1 Europe Biological Drugs Sales by Country
7.1.2 Europe Biological Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biological Drugs Market Facts & Figures by Type
7.3 Europe Biological Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Biological Drugs by Region
8.1.1 Asia Pacific Biological Drugs Sales by Region
8.1.2 Asia Pacific Biological Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biological Drugs Market Facts & Figures by Type
8.3 Asia Pacific Biological Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Biological Drugs by Country
9.1.1 Latin America Biological Drugs Sales by Country
9.1.2 Latin America Biological Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biological Drugs Market Facts & Figures by Type
9.3 Central & South America Biological Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Biological Drugs by Country
10.1.1 Middle East and Africa Biological Drugs Sales by Country
10.1.2 Middle East and Africa Biological Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biological Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Biological Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description and Business Overview
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Biological Drugs Products Offered
11.2.5 Eli Lilly Related Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Description and Business Overview
11.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda Biological Drugs Products Offered
11.3.5 Takeda Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Biological Drugs Products Offered
11.4.5 Pfizer Related Developments
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Description and Business Overview
11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Biological Drugs Products Offered
11.5.5 Amgen Related Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Corporation Information
11.6.2 F. Hoffmann-La Roche Description and Business Overview
11.6.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered
11.6.5 F. Hoffmann-La Roche Related Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Description and Business Overview
11.7.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Biological Drugs Products Offered
11.7.5 Johnson & Johnson Related Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Description and Business Overview
11.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck Biological Drugs Products Offered
11.8.5 Merck Related Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Corporation Information
11.9.2 Abbott Laboratories Description and Business Overview
11.9.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Abbott Laboratories Biological Drugs Products Offered
11.9.5 Abbott Laboratories Related Developments
11.10 Baxter
11.10.1 Baxter Corporation Information
11.10.2 Baxter Description and Business Overview
11.10.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Baxter Biological Drugs Products Offered
11.10.5 Baxter Related Developments
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
11.12 Biogen
11.12.1 Biogen Corporation Information
11.12.2 Biogen Description and Business Overview
11.12.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Biogen Products Offered
11.12.5 Biogen Related Developments
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Corporation Information
11.13.2 GlaxoSmithKline Description and Business Overview
11.13.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.13.4 GlaxoSmithKline Products Offered
11.13.5 GlaxoSmithKline Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biological Drugs Market Estimates and Projections by Region
12.1.1 Global Biological Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Biological Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Biological Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Biological Drugs Sales Forecast (2021-2026)
12.2.2 North America: Biological Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Biological Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Biological Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Biological Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Biological Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Biological Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biological Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biological Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biological Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biological Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Biological Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Biological Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Biological Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Biological Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biological Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biological Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biological Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biological Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biological Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biological Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Bristol-Myers Squibb、Eli Lilly、Takeda、Pfizer、Amgen、F. Hoffmann-La Roche、Johnson & Johnson、Merck、Abbott Laboratories、Baxter、Novartis、Biogen、GlaxoSmithKline

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の生物製剤市場2026:インサイト・予測(Global Biological Drugs Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。